C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/04 (2006.01) A61K 35/14 (2006.01) A61K 38/37 (2006.01) A61K 47/40 (2006.01) A61L 2/04 (2006.01)
Patent
CA 2252374
A process for the viral inactivation of lyophilized blood proteins, particularly Factor VIII, by heat comprising forming a stable complex between the blood protein and a cyclodextrin in an aqueous solution. The solution is then lyophilized and the blood protein/cyclodextrin complex is recovered. The lyophilized blood protein/cyclodextrin is then heated, e.g., to 80 °C for 72 hours, to inactivate any virus present. The material may then be reconstituted prior to administration to a patient.
Procédé d'inactivation de virus dans des protéines sanguines lyophilisées, en particulier le Facteur VIII, au moyen de la chaleur, consistant à former un complexe stable entre la protéine sanguine et une cyclodextrine dans une solution aqueuse. La solution est ensuite lyophilisée et le complexe protéine sanguine/cyclodextrine récupéré. Ce complexe lyophilisé est ensuite chauffé, par exemple à 80 DEG C pendant 72 heures, afin d'inactiver tout virus présent. La substance peut ensuite être reconstituée avant d'être administrée à un patient.
Bhattacharya Prabir
Motokubota Toshiharu
Alpha Therapeutic Corporation
Fetherstonhaugh & Co.
LandOfFree
A process for viral inactivation of lyophilized blood proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A process for viral inactivation of lyophilized blood proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A process for viral inactivation of lyophilized blood proteins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1370992